Condition: Asthma
Interventions: Drug: QAV680; Drug: QAV680 Placebo
Sponsor: Novartis Pharmaceuticals
Terminated – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma
Condition: Asthma
Interventions: Drug: Tiotropium bromide; Drug: tiotropium bromide; Drug: tiotropium bromide; Drug: Placebo
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma
Condition: Asthma
Interventions: Drug: Placebo; Drug: Tiotropium 5 µg q.d.; Drug: Tiotropium 2.5 µg b.i.d.
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma
Condition: Asthma
Interventions: Drug: FP 100mcg BID plus GSK2190915 100mg QD (AM); Drug: FP 100mcg BID plus GSK2190915 300mg QD (AM); Drug: FP 100mcg BID plus montelukast 10mg QD (PM); Drug: FP 100mcg BID plus placebo BID; Drug: FP/SAL 100/50mcg BID plus placebo BID
Sponsor: GlaxoSmithKline
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
Condition: Asthma
Interventions: Drug: Fluticasone propionate inhalation powder; Drug: Fluticasone furoate inhalation powder; Drug: Placebo inhalation powder
Sponsor: GlaxoSmithKline
Recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
Condition: Asthma Patients
Interventions: Drug: AZD1981; Drug: AZD1981; Drug: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
New Combination for Asthma Shows Encouraging Results in Delivering Efficacy … – PR Newswire UK (press release)
|
New Combination for Asthma Shows Encouraging Results in Delivering Efficacy …
PR Newswire UK (press release) The FP/FORM combination has also been shown to be more effective in controlling asthma symptoms than FP alone(2). Despite a range of available therapies, … |
View full post on asthma – Google News